Caption Management, LLC Seres Therapeutics, Inc. Call Options Transaction History

Caption Management, LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	BUY	$2.33 - $5.07 $116,500 - $253,500	50,000 New	50,000 $119,000
Q1 2023 May 15, 2023	BUY	$4.95 - $6.09 $198,000 - $243,600	40,000 New	40,000 $226,000
Q2 2022 Aug 15, 2022	SELL	$2.7 - $7.62 $270,000 - $762,000	-100,000 Reduced 66.67%	50,000 $172,000
Q1 2022 May 13, 2022	BUY	$6.3 - $8.84 $945,000 - $1.33 Million	150,000 New	150,000 $1.07 Million
Q4 2021 Feb 11, 2022	SELL	$6.02 - $11.43 $421,399 - $800,100	-70,000 Closed	0 $0

Q3 2021 Nov 12, 2021	SELL	$5.46 - $22.6 $639,912 - $2.65 Million	-117,200 Reduced 62.61%	70,000 $487,000
Q2 2021 Aug 16, 2021	BUY	$18.46 - $24.36 $2.44 Million - $3.23 Million	132,400 Added 241.61%	187,200 $4.47 Million
Q1 2021 May 17, 2021	BUY	$17.66 - $28.92 $967,768 - $1.58 Million	54,800 New	54,800 $1.13 Million
Q4 2020 Feb 16, 2021	SELL	$23.25 - $37.73 $7.86 Million - $12.8 Million	-338,100 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$3.74 - $28.74 $1.26 Million - $9.72 Million	338,100 New	338,100 $9.57 Million

100

62.7M

36.9K

476K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $86.9M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.